e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Septerna, Inc. - Common Stock
(NQ:
SEPN
)
22.57
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
64
Open
22.57
Bid (Size)
20.30 (1)
Ask (Size)
22.56 (1)
Prev. Close
22.57
Today's Range
22.57 - 22.57
52wk Range
4.170 - 28.99
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
October 15, 2025
Novo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments
Via
MarketBeat
Topics
World Trade
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
September 29, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Performance
YTD
+5.7%
+5.7%
1 Month
+56.3%
+56.3%
3 Month
+78.8%
+78.8%
6 Month
+282.5%
+282.5%
1 Year
+5.4%
+5.4%
More News
Read More
Septerna to Participate in Upcoming Investor Conferences
August 27, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
August 21, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
August 11, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside
June 23, 2025
Via
Benzinga
This Ventas Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
June 23, 2025
Via
Benzinga
This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
June 23, 2025
Via
Benzinga
The Analyst Verdict: Septerna In The Eyes Of 4 Experts
June 23, 2025
Via
Benzinga
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
May 29, 2025
Via
Investor's Business Daily
Septerna to Present at Jefferies Global Healthcare Conference
May 29, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Analysts Think These Stocks Could More Than Double in Value
May 23, 2025
Via
MarketBeat
Topics
World Trade
Where Septerna Stands With Analysts
May 16, 2025
Via
Benzinga
3 Stocks That Will Profit From Trump's Drug Price Cut
May 16, 2025
Via
Benzinga
Topics
Government
Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role
May 16, 2025
Via
Benzinga
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
May 15, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Which stocks have an unusual volume on Thursday?
May 15, 2025
Via
Chartmill
Is It Time to Buy the Dip in Novo Nordisk Stock?
May 15, 2025
Via
MarketBeat
Topics
Government
Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session.
May 14, 2025
Via
Chartmill
Money Movers: HIT, SEPN, ALUR, LUCY, PRSO – Biotech, Healthcare, AI & Weight Loss Innovators Lead Momentum Surge – More Stocks Inside
May 14, 2025
Via
AB Newswire
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 14, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
May 14, 2025
Via
Chartmill
Dow Edges Higher; US Crude Oil Inventories Increase
May 14, 2025
Via
Benzinga
Topics
Stocks
Wednesday's pre-market session: top gainers and losers
May 14, 2025
Via
Chartmill
Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs
May 14, 2025
Via
Benzinga
Frequently Asked Questions
Is Septerna, Inc. - Common Stock publicly traded?
Yes, Septerna, Inc. - Common Stock is publicly traded.
What exchange does Septerna, Inc. - Common Stock trade on?
Septerna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Septerna, Inc. - Common Stock?
The ticker symbol for Septerna, Inc. - Common Stock is SEPN on the Nasdaq Stock Market
What is the current price of Septerna, Inc. - Common Stock?
The current price of Septerna, Inc. - Common Stock is 22.57
When was Septerna, Inc. - Common Stock last traded?
The last trade of Septerna, Inc. - Common Stock was at 10/16/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert